Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk.
about
Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies.Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group.Right patient, right treatment, right time: biosignatures and precision medicine in depression.Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision
P2860
Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Quest for biomarkers of treatm ...... ting the paradigm toward risk.
@ast
Quest for biomarkers of treatm ...... ting the paradigm toward risk.
@en
type
label
Quest for biomarkers of treatm ...... ting the paradigm toward risk.
@ast
Quest for biomarkers of treatm ...... ting the paradigm toward risk.
@en
prefLabel
Quest for biomarkers of treatm ...... ting the paradigm toward risk.
@ast
Quest for biomarkers of treatm ...... ting the paradigm toward risk.
@en
P2860
P356
P1476
Quest for biomarkers of treatm ...... ting the paradigm toward risk.
@en
P2093
Donald F Smith
P2860
P356
10.3389/FPSYT.2013.00057
P577
2013-06-18T00:00:00Z